Q1 2020 Holdings
Filed 2020-05-15 | 43 holdings | $556.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma(ASND) | Sponsored ADR | 04351P101 | $201.2M | 1,787,000 | 36.2% |
| Biomarin Pharmaceutical Inc(BMRN) | Common | 09061G101 | $163.1M | 1,930,000 | 29.3% |
| Argenx SE(ARGX) | Sponsored ADR | 04016X101 | $123.4M | 936,500 | 22.2% |
| Aurinia Pharmaceuticals Inc(AUPH) | Common | 05156V102 | $25.0M | 1,725,000 | 4.5% |
| Allogene Therapeutics Inc(ALLO) | Common | 019770106 | $21.9M | 1,128,594 | 3.9% |
| Black Diamond Therapeutics Inc(BDTX) | Common | 09203E105 | $13.0M | 521,750 | 2.3% |
| Acadia Pharmaceuticals Inc(ACAD) | Common | 004225108 | $6.1M | 145,000 | 1.1% |
| Immunomedics Inc(IMMU) | Common | 452907108 | $330.3K | 24,500,000 | 0.1% |
| Mirati Therapeutics Inc(MRTXEUR) | Common | 60468T105 | $316.1K | 4,112,700 | 0.1% |
| Iovance Biotherapeutics Inc(IOVA) | Common | 462260100 | $269.7K | 9,010,413 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | Common | 803607100 | $155.0K | 1,585,000 | 0.0% |
| Horizon Therapeutics PLC | Common | G46188101 | $135.5K | 4,575,000 | 0.0% |
| Karyopharm Therapeutics Inc(KPTIEUR) | Common | 48576U106 | $134.5K | 7,000,000 | 0.0% |
| Constellation Pharmaceuticals Inc(CNST) | Common | 210373106 | $114.7K | 3,650,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | Common | 03152W109 | $101.2K | 10,950,000 | 0.0% |
| Deciphera Pharmaceuticals Inc(DCPHEUR) | Common | 24344T101 | $82.3K | 2,000,000 | 0.0% |
| Uniqure NV(QURE) | Common | N90064101 | $78.3K | 1,650,000 | 0.0% |
| Acceleron Pharma Inc(XLRN) | Common | 00434H108 | $77.3K | 860,000 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | Common | 00773U108 | $69.9K | 7,150,000 | 0.0% |
| Zogenix Inc | Common | 98978L204 | $69.2K | 2,800,000 | 0.0% |
| Myokardia Inc | Common | 62857M105 | $67.3K | 1,435,000 | 0.0% |
| PTC Therapeutics Inc(PTCT) | Common | 69366J200 | $53.5K | 1,200,000 | 0.0% |
| Relmada Therapeutics Inc(RLMD) | Common | 75955J402 | $39.2K | 1,150,000 | 0.0% |
| Athenex Inc(ATNXEUR) | Common | 04685N103 | $37.7K | 4,875,000 | 0.0% |
| Avadel Pharmaceuticals PLC | Sponsored ADR | 05337M104 | $34.7K | 4,365,655 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | Common | 98420N105 | $31.4K | 2,772,000 | 0.0% |
| Tricida Inc(1T7) | Common | 89610F101 | $30.0K | 1,365,000 | 0.0% |
| Sage Therapeutics Inc(SG7) | Common | 78667J108 | $28.7K | 1,000,000 | 0.0% |
| CUE Biopharma Inc(CUE) | Common | 22978P106 | $26.5K | 1,870,000 | 0.0% |
| Madrigal Pharmaceuticals Inc(MDGL) | Common | 558868105 | $23.3K | 349,000 | 0.0% |
| Trillium Therapeutics Inc | Common | 89620X506 | $20.0K | 4,950,000 | 0.0% |
| Marinus Pharmaceuticals Inc | Common | 56854Q101 | $12.6K | 6,200,000 | 0.0% |
| Biodelivery Sciences Intl(BDSIUSD) | Common | 09060J106 | $11.4K | 3,000,000 | 0.0% |
| Revolution Medicines Inc(RVMD) | Common | 76155X100 | $9.9K | 450,000 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | Common | 23257D103 | $8.1K | 5,500,000 | 0.0% |
| Amarin Corp PLC | Sponsored ADR | 023111206 | $8.0K | 2,000,000 | 0.0% |
| TG Therapeutics Inc(TGTX) | Common | 88322Q108 | $7.9K | 800,000 | 0.0% |
| Agenus Inc(AGENEUR) | Common | 00847G705 | $6.7K | 2,750,000 | 0.0% |
| Fennec Pharmaceuticals Inc(FENC) | Common | 31447P100 | $6.6K | 1,105,999 | 0.0% |
| Immunogen Inc(IMGNEUR) | Common | 45253H101 | $6.5K | 1,900,000 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA)Call | Common | 462260100 | $3.1K | 1,250,000 | 0.0% |
| Alimera Sciences Inc | Common | 016259202 | $1.6K | 415,999 | 0.0% |
| Amarin Corp PLCCall | Sponsored ADR | 023111206 | $10 | 1,000,000 | 0.0% |